Abstract:We have cloned and functionally expressed a sodium-dependent human nucleoside transporter, hCNT2, from a CNS cancer cell line U251. Our cDNA clone of hCNT2 had the same predicted amino acid sequence as the previously cloned hCNT2 transporter. Of the several cell lines studied, the best hCNT2 transport function was obtained when transiently expressed in U251 cells. Na(+)-dependent uptake of [3H]inosine in U251 cells transiently expressing hCNT2 was 50-fold greater than that in non-transfected cells, and uptake in Na(+)-containing medium was approximately 30-fold higher than that at Na(+)-free condition. The hCNT2 displayed saturable uptake of [3H]inosine with K(m) of 12.8 microM and V(max) of 6.66 pmol/mg protein/5 min. Uptake of [3H]inosine was significantly inhibited by the purine nucleoside drugs dideoxyinosine and cladribine, but not by acyclic nucleosides including acyclovir, ganciclovir, and their prodrugs valacyclovir and valganciclovir. This indicates that the closed ribose ring is important for binding of nucleoside drugs to hCNT2. Among several pyrimidine nucleosides, hCNT2 favorably interacted with the uridine analogue floxuridine. Interestingly, we found that benzimidazole analogues, including maribavir, 5,6-dichloro-2-bromo-1-beta-D-ribofuranosylbenzimidazole (BDCRB), and 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), were strong inhibitors of inosine transport, even though they have a significantly different heterocycle structure compared to a typical purine ring. As measured by GeneChip arrays, mRNA expression of hCNT2 in human duodenum was 15-fold greater than that of hCNT1 or hENT2. Further, the rCNT2 expression in rat duodenum was 20-fold higher than rCNT1, rENT1 or rENT2. This suggests that hCNT2 (and rCNT2) may have a significant role in uptake of nucleoside drugs from the intestine and is a potential transporter target for the development of nucleoside and nucleoside-mimetic drugs.

Allosteric and transport modulation of human concentrative nucleoside transporter 3 at the atomic scale

Vectorial transport of nucleoside analogs from the apical to the basolateral membrane in double-transfected cells expressing the human concentrative nucleoside transporter hCNT3 and the export pump ABCC4

Cryo-EM structure of the human concentrative nucleoside transporter CNT3

Cooperative Transport Mechanism of Human Monocarboxylate Transporter 2

Structural Insights into the Mechanisms of Urea Permeation and Distinct Inhibition Modes of Urea Transporters

Molecular basis for substrate recognition by the bacterial nucleoside transporter NupG

Structural Mechanisms of Human Sodium-Coupled High-Affinity Choline Transporter CHT1

The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs

Transport of nucleosides in the vcCNT facilitated by sodium gradients from molecular dynamics simulations.

Antiviral drug recognition and elevator-type transport motions of CNT3

Functional Characterization of Human Equilibrative Nucleoside Transporter 1

Substrate-induced Conformational Dynamics of the Dopamine Transporter

Functional characterization of a H+/nucleoside co-transporter (CaCNT) from Candida albicans, a fungal member of the concentrative nucleoside transporter (CNT) family of membrane proteins

Cytoophidia: a conserved yet promising mode of enzyme regulation in nucleotide metabolism

Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum

Human Nucleoside Transporters: Biomarkers for Response to Nucleoside Drugs

Mechanistic insights of substrate transport and inhibitor binding revealed by high-resolution structures of human norepinephrine transporter

Structural Basis of Adenine Nucleotides Regulation and Neurodegenerative Pathology in ClC-3 Exchanger

Structural Models of Human Norepinephrine Transporter Ensemble Reveal the Allosteric Sites and Ligand-Binding Mechanism

Structural insights into human organic cation transporter 1 transport and inhibition

Monoamine transporters: vulnerable and vital doorkeepers.